Stock Market News
Results Round-up
24-10-2012 16:20
| Add To Google +1 | Tweet |
Shares in household products and personal care behemoth Reckitt Benckiser jumped after it produced solid results for the third quarter, with like-for-like net revenue growth of four per cent at constant exchange rates driven by strong growth in emerging markets. It also said it will meet growth expectations.
For the year-to-date (YTD), net revenues of £7,091m were also up 4% on a like-for-like basis. However, if you include the impact of exchange rates, net revenues for the year to date were flat compared with the same period in 2011.
Rakesh Kapoor, Chief Executive Officer, said: "Reckitt Benckiser's strong third quarter results were underpinned by an excellent performance in emerging markets and an improved performance in Europe North America. Growth came from all core areas and categories. RBP continues to make very good progress with Suboxone sublingual film. I am very pleased that our new strategy and our renewed commitment to managing the business for the long term are showing encouraging results.
"Our results give us the confidence to reiterate our FY 2012 target of like-for-like net revenue growth (excluding its RBP acquisition) of 200bps above our market growth rate. We now expect market growth to be at the top end of the 1-2% range. We continue to expect to maintain full year operating margins."
In Europe and North America, which delivered 55% of core net revenues, total net revenues YTD decreased to £3,442m with flat like-for-like growth.
Within this geographic area, Gaviscon and Durex delivered strong results for the health division, though this was offset by weakness YTD in seasonal brands such as Mucinex, Strepsils and certain products within Nurofen on the back of a slower start to the 'flu season earlier in the year.
Its Hygiene brands of Lysol and Finish performed strongly, particularly in the US behind new initiatives, such as Lysol Power & Free, Finish Quantum and All-in-1 gel packs and tablets. In the Home category, Vanish shares showed positive momentum, although the market is still down.
In Latin America and Asia-Pacific, which delivered 28% of core net revenues, total net revenues YTD increased 11% at constant exchange rates to £1,736m, with like-for-like growth of 11%.
In Health, Paras brands in India and Durex, particularly in China, grew very strongly. In Hygiene, Dettol, Finish, and Harpic delivered strong growth behind initiatives such as Dettol Daily Care, Re-energize, and High Performance for Men soap and shower gels. Surface cleaners continued to experience good growth across the Area. Vanish and Air Wick performed well in the Home category.
In Russia, the Middle East and Africa, which delivered 17% of core net revenue, total net revenues YTD increased 8% at constant exchange rates to £1,077m with like-for-like growth of 8%.
On a category basis Health growth was driven by Durex, Gaviscon and Strepsils. Hygiene performed particularly well behind Dettol, Finish, Harpic and Veet driven by initiatives such as Dettol Daily Care and Re-energize. Air Wick performed well in the Home category.
Wealth manager Rathbone Brothers has provided a solid quarterly trading update on Wednesday with funds under management (FuM) slightly up on the same period in the prior year.
Total FuM for the nine months to September 30th were £17.35bn (2011: £15.05bn), with net operating income increasing to £116m (2011: £108.7m) for the period.
Underlying net operating income of £109.4m in Rathbone Investment Management for the nine months ended September 30th was 7.9% higher than 2011.
Net interest income of £7.6m in the first nine months of 2012 was in line with the same period in 2011. The company commented: "Pressure on interest margins is expected to continue into 2013".
"We expect markets to remain challenging for the remainder of 2012 reflecting a weak outlook for global growth and continuing nervousness over the future of the Eurozone," said Chief Executive Officer Andy Pomfret.
"Despite this, we will continue to invest and grow as a leading provider of high-quality personalised discretionary investment management services in the post RDR world."
For the year-to-date (YTD), net revenues of £7,091m were also up 4% on a like-for-like basis. However, if you include the impact of exchange rates, net revenues for the year to date were flat compared with the same period in 2011.
Rakesh Kapoor, Chief Executive Officer, said: "Reckitt Benckiser's strong third quarter results were underpinned by an excellent performance in emerging markets and an improved performance in Europe North America. Growth came from all core areas and categories. RBP continues to make very good progress with Suboxone sublingual film. I am very pleased that our new strategy and our renewed commitment to managing the business for the long term are showing encouraging results.
"Our results give us the confidence to reiterate our FY 2012 target of like-for-like net revenue growth (excluding its RBP acquisition) of 200bps above our market growth rate. We now expect market growth to be at the top end of the 1-2% range. We continue to expect to maintain full year operating margins."
In Europe and North America, which delivered 55% of core net revenues, total net revenues YTD decreased to £3,442m with flat like-for-like growth.
Within this geographic area, Gaviscon and Durex delivered strong results for the health division, though this was offset by weakness YTD in seasonal brands such as Mucinex, Strepsils and certain products within Nurofen on the back of a slower start to the 'flu season earlier in the year.
Its Hygiene brands of Lysol and Finish performed strongly, particularly in the US behind new initiatives, such as Lysol Power & Free, Finish Quantum and All-in-1 gel packs and tablets. In the Home category, Vanish shares showed positive momentum, although the market is still down.
In Latin America and Asia-Pacific, which delivered 28% of core net revenues, total net revenues YTD increased 11% at constant exchange rates to £1,736m, with like-for-like growth of 11%.
In Health, Paras brands in India and Durex, particularly in China, grew very strongly. In Hygiene, Dettol, Finish, and Harpic delivered strong growth behind initiatives such as Dettol Daily Care, Re-energize, and High Performance for Men soap and shower gels. Surface cleaners continued to experience good growth across the Area. Vanish and Air Wick performed well in the Home category.
In Russia, the Middle East and Africa, which delivered 17% of core net revenue, total net revenues YTD increased 8% at constant exchange rates to £1,077m with like-for-like growth of 8%.
On a category basis Health growth was driven by Durex, Gaviscon and Strepsils. Hygiene performed particularly well behind Dettol, Finish, Harpic and Veet driven by initiatives such as Dettol Daily Care and Re-energize. Air Wick performed well in the Home category.
Wealth manager Rathbone Brothers has provided a solid quarterly trading update on Wednesday with funds under management (FuM) slightly up on the same period in the prior year.
Total FuM for the nine months to September 30th were £17.35bn (2011: £15.05bn), with net operating income increasing to £116m (2011: £108.7m) for the period.
Underlying net operating income of £109.4m in Rathbone Investment Management for the nine months ended September 30th was 7.9% higher than 2011.
Net interest income of £7.6m in the first nine months of 2012 was in line with the same period in 2011. The company commented: "Pressure on interest margins is expected to continue into 2013".
"We expect markets to remain challenging for the remainder of 2012 reflecting a weak outlook for global growth and continuing nervousness over the future of the Eurozone," said Chief Executive Officer Andy Pomfret.
"Despite this, we will continue to invest and grow as a leading provider of high-quality personalised discretionary investment management services in the post RDR world."
| Related share prices |
|---|
Stock News is provided by Digital Look Corporate Solutions from Sharecast news. Please read the terms and conditions of useage of this data. Republication or redistribution of content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd.
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- UK 100 Shares
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways share price
- Centrica share price
- Tesco share price
- National Grid share price
- RBS share price
- GSK share price
- Marks and Spencer
- Rolls Royce
- Banco Santander price
- Direct Line
- Rio Tinto share price
- Amec Share price
- Corac share price
- Lookers
- Telecom plus
- Kier share price
- Punch taverns
- Blinkx share price
- Tan share price
- Yell share price
- Rsa share price
- Pendragon share price
- Logica share price
- Bat share price
- Sky share price
- Kingfisher share price
- Dragon Oil share price
- Desire Petroleum share price
- RRL share price
- BPC share price
- VOG share price
- SAR share price


Prices

